- Section 1 - About the Company
- Takeda Pharmaceutical Co Ltd - Key Facts
- Takeda Pharmaceutical Co Ltd - Key Employees
- Takeda Pharmaceutical Co Ltd - Key Employee Biographies
- Takeda Pharmaceutical Co Ltd - Major Products and Services
- Takeda Pharmaceutical Co Ltd - History
- Takeda Pharmaceutical Co Ltd - Company Statement
- Takeda Pharmaceutical Co Ltd - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Joint Venture
- Section 2 – Company Analysis
- Company Overview
- Takeda Pharmaceutical Co Ltd - Business Description
- Product Category: Gastroenterology
- Overview
- Performance
- Product Category: Neuroscience
- Overview
- Performance
- Product Category: Oncology
- Overview
- Performance
- Product Category: Other
- Performance
- Product Category: PDT Immunology
- Overview
- Performance
- Product Category: Rare Genetics and Other
- Performance
- Product Category: Rare Hematology
- Overview
- Performance
- Geographical Segment: Asia (excluding Japan)
- Performance
- Geographical Segment: Europe and Canada
- Performance
- Geographical Segment: Japan
- Performance
- Geographical Segment: Latin America
- Performance
- Geographical Segment: Other
- Performance
- Geographical Segment: Russia/CIS
- Performance
- Geographical Segment: U.S
- Performance
- R&D Overview
- Takeda Pharmaceutical Co Ltd - Corporate Strategy
- Takeda Pharmaceutical Co Ltd - SWOT Analysis
- SWOT Analysis - Overview
- Takeda Pharmaceutical Co Ltd - Strengths
- Takeda Pharmaceutical Co Ltd - Weaknesses
- Takeda Pharmaceutical Co Ltd - Opportunities
- Takeda Pharmaceutical Co Ltd - Threats
- Takeda Pharmaceutical Co Ltd - Key Competitors
- Section 3 – Company Financial Ratios
- Financial Ratios - Capital Market Ratios
- Financial Ratios - Annual Ratios
- Performance Chart
- Financial Performance
- Financial Ratios - Interim Ratios
- Financial Ratios - Ratio Charts
- Section 4 – Company’s Lifesciences Financial Deals and Alliances
- Takeda Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
- Takeda Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
- Takeda Pharmaceutical Co Ltd, Recent Deals Summary
- Section 5 – Company’s Recent Developments
- Oct 30, 2024: Takeda Reports H1 FY2024 Results
- Oct 18, 2024: Targeted Therapy, Driven by Comprehensive Genomic Profiling and Molecular Tumour Board, Improves Outcomes In Pretreated Patients with Metastatic Cancer
- Sep 18, 2024: Takeda Commits Over $32 Million in Five New Global Corporate Social Responsibility Partnerships To Further Drive Health Impact in 93 Countries
- Aug 15, 2024: Nanoform Joins Forces With Takeda on Plasma-Derived Therapy Development
- Jul 31, 2024: Takeda Announces First Quarter FY2024 Results – Strong Performance by Growth & Launch Products; Advancements in Promising Late-Stage Pipeline
- Jul 17, 2024: nference Establishes AI Initiative with Takeda to Advance Precision Medicine in Inflammatory Bowel Disease
- Jul 16, 2024: PET-2-Guided BrECADD Better Tolerated and More Effective than eBEACOPP in Patients with Newly Diagnosed, Advanced-Stage cHL
- Jun 26, 2024: Takeda Announces New Assignments of Directors
- May 21, 2024: Inspire and Takeda Researchers to Present Novel Study on Short Bowel Syndrome Patient Experience at DDW2024
- May 14, 2024: Takeda to Present Oncology Portfolio and Pipeline Data at the 2024 ASCO Annual Meeting
- Section 6 – Appendix
- Methodology
- Ratio Definitions
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Takeda Pharmaceutical Co Ltd, Key Facts
- Takeda Pharmaceutical Co Ltd, Key Employees
- Takeda Pharmaceutical Co Ltd, Key Employee Biographies
- Takeda Pharmaceutical Co Ltd, Major Products and Services
- Takeda Pharmaceutical Co Ltd, History
- Takeda Pharmaceutical Co Ltd, Other Locations
- Takeda Pharmaceutical Co Ltd, Subsidiaries
- Takeda Pharmaceutical Co Ltd, Joint Venture
- Takeda Pharmaceutical Co Ltd, Key Competitors
- Takeda Pharmaceutical Co Ltd, Ratios based on current share price
- Takeda Pharmaceutical Co Ltd, Annual Ratios
- Takeda Pharmaceutical Co Ltd, Annual Ratios (Cont...1)
- Takeda Pharmaceutical Co Ltd, Annual Ratios (Cont...2)
- Takeda Pharmaceutical Co Ltd, Interim Ratios
- Takeda Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
- Takeda Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
- Takeda Pharmaceutical Co Ltd, Recent Deals Summary
- Currency Codes
- Capital Market Ratios
- Equity Ratios
- Profitability Ratios
- Cost Ratios
- Liquidity Ratios
- Leverage Ratios
- Efficiency Ratios
- List of Figures
- Takeda Pharmaceutical Co Ltd, Performance Chart (2020 - 2024)
- Takeda Pharmaceutical Co Ltd, Ratio Charts
- Takeda Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
- Takeda Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2018 to YTD 2024
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook